Can Heart Failure Blood Tests Be Used During Pregnancy? A Review of BNP in Pregnant Women

BNP and NT-proBNP are well-established heart failure markers, but their clinical utility during pregnancy remains limited due to physiological changes.

Quek, Stuart et al.·Obstetric medicine·2025·low-moderateNarrative Review
RPEP-13155Narrative Reviewlow-moderate2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Narrative Review
Evidence
low-moderate
Sample
N=N/A (review)
Participants
Pregnant women with or at risk of cardiac complications

What This Study Found

BNP/NT-proBNP show promise for cardiac assessment in pregnancy but are limited by physiological elevations and lack of pregnancy-specific reference ranges.

Key Numbers

No specific thresholds established; reviews available literature on BNP/NT-proBNP in pregnancy.

How They Did This

Systematic review of Medline, PubMed, Cochrane Register, and Cochrane Database on BNP use in pregnancy.

Why This Research Matters

Cardiac disease in pregnancy is a leading cause of maternal death — better diagnostic tools could save lives.

The Bigger Picture

Establishing pregnancy-specific cardiac biomarker thresholds would fill a major gap in obstetric cardiovascular care.

What This Study Doesn't Tell Us

Limited and heterogeneous evidence base. Pregnancy-specific reference ranges remain undefined.

Questions This Raises

  • ?What BNP cutoffs should be used for heart failure diagnosis in pregnant women?
  • ?Can serial BNP measurements improve risk stratification during pregnancy?

Trust & Context

Key Stat:
Limited utility Physiological BNP elevation during normal pregnancy complicates heart failure diagnosis
Evidence Grade:
Systematic review — good methodology but limited by the sparse and heterogeneous evidence base.
Study Age:
Published in 2025, addressing an ongoing gap in obstetric cardiology.
Original Title:
Usefulness of brain-type natriuretic peptide (BNP) levels in pregnancy.
Published In:
Obstetric medicine, 1753495X251398074 (2025)
Database ID:
RPEP-13155

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research without a strict systematic method.

What do these levels mean? →

Frequently Asked Questions

Can BNP tests detect heart problems during pregnancy?

BNP shows promise but normal pregnancy raises BNP levels, making it harder to distinguish normal changes from heart failure without pregnancy-specific cutoffs.

Why is heart disease dangerous in pregnancy?

Pregnancy puts extra strain on the heart, and cardiac disease is a leading cause of maternal death — early detection is critical but current tools have limitations.

Read More on RethinkPeptides

Cite This Study

RPEP-13155·https://rethinkpeptides.com/research/RPEP-13155

APA

Quek, Stuart; Zill-E-Huma, Rabia; Andrews, Mark; Mouyis, Maria. (2025). Usefulness of brain-type natriuretic peptide (BNP) levels in pregnancy.. Obstetric medicine, 1753495X251398074. https://doi.org/10.1177/1753495X251398074

MLA

Quek, Stuart, et al. "Usefulness of brain-type natriuretic peptide (BNP) levels in pregnancy.." Obstetric medicine, 2025. https://doi.org/10.1177/1753495X251398074

RethinkPeptides

RethinkPeptides Research Database. "Usefulness of brain-type natriuretic peptide (BNP) levels in..." RPEP-13155. Retrieved from https://rethinkpeptides.com/research/quek-2025-usefulness-of-braintype-natriuretic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.